Warner Chilcott LimitedRockaway, NJ, United States (NASDAQ (GM): WCRX)

Tools:

Buy A ReportBecome A Subscriber

Today's Special Offer

Warner Chilcott Limited Financial Statements

Warner Chilcott Limited Financial Information

Company Type Public
Headquarters
Fiscal Year-End December
Annual Report Company Web Site
Investor Relations Company Web Site
Edgar Online logo
This data is provided as per license from EDGAR Online

Warner Chilcott Limited Income Statement

  2007 2006 2005
Revenue ($ mil.) 899.6 754.5 515.3
Gross Profit ($ mil.) 713.6 602.7 420.0
Operating Income ($ mil.) 164.9 68.5 (390.3)
Total Net Income ($ mil.) 28.9 (153.5) (556.7)
Diluted EPS (Net Income) 0.12 (1.63) (7.19)
More Warner Chilcott Limited financial information

Warner Chilcott Limited Stock Quote & Chart

10/10/08 15:00:19 EST • NASDAQ • 11.94 • Decreased by -0.8200 • Decreased by -6.4263 %
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
Detailed QuoteInteractive Stock Chart

Warner Chilcott Limited Financial Ratios

  Company Industry
Median		 Market
Median1
Price/Sales Ratio 4.45 3.66 1.55
Price/Earnings Ratio 42.84 15.34 15.75
Price/Book Ratio 2.86 2.93 1.49
Price/Cash Flow Ratio 15.23 12.16 9.68
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.

Detailed Warner Chilcott Limited Financial Ratios

Warner Chilcott Limited Competitive Intelligence

Barr Pharmaceuticals Bayer HealthCare Pharmaceuticals Galderma Laboratories
Annual Sales ($ mil.) 2,500.6 1,258.9 430.0
Employees 8,900 2,000 369
Market Cap ($ mil.) 7,293.7 -- --

Competitive Landscape